News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biothera Broadens Understanding Of Biomarker For Cancer Immunotherapy Imprime PGG


12/5/2013 7:50:42 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

EAGAN, Minn.--(BUSINESS WIRE)--Biothera researchers have broadened their understanding of a biomarker that may enable doctors to predict which cancer patients will best respond to Imprime PGG®, the company’s immunotherapy in Phase 3 drug development for colorectal cancer. The new findings will be presented today at the VIC Congress - Vaccines, Immunotherapies and Cell Therapies, in Brussels.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
Biothera
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES